However, human nonalcoholic steatohepatitis (fatty liver with inflammation and fibrosis) is associated with inappropriately low levels of hepatic XBP1 expression compared with bland hepatic steatosis (fatty liver without inflammation and fibrosis) (Puri et al. 2008). Here, XBP1 is linked to metabolic dysfunction-associated steatohepatitis.